Page 2390 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2390

2132   Part XII  Hemostasis and Thrombosis


         7.  Rohatgi A, Khera A, Berry JD, et al: HDL cholesterol efflux capacity and   21.  Massberg S, Brand K, Grüner S, et al: A critical role of platelet adhe-
           incident cardiovascular events. N Engl J Med 371:2383–2393, 2014.  sion  in  the  initiation  of  atherosclerotic  lesion  formation.  J  Exp  Med
         8.  Fernández-Hernando  C,  Moore  KJ:  MicroRNA  modulation  of   196:887–896, 2002.
           cholesterol  homeostasis.  Arterioscler  Thromb  Vasc  Biol  31:2378–2382,   22.  Finn  AV,  Nakano  M,  Narula  J,  et al:  Concept  of  vulnerable/unstable
           2011.                                                 plaque. Arterioscler Thromb Vasc Biol 30:1282–1292, 2010.
         9.  Goff DC, Jr, Lloyd-Jones DM, Bennett G, et al: ACC/AHA guideline on   23.  Dweck MR, Doris MK, Motwani M, et al: Imaging of coronary athero-
           the assessment of cardiovascular risk: a report of the American College   sclerosis – evolution towards new treatment strategies. Nat Rev Cardiol
           of  Cardiology/  American  Heart  Association  Task  Force  of  Practice   13:533–548, 2016.
           Guidelines. Circulation 129:S49–S73, 2014.         24.  Scull  CM,  Tabas  I:  Mechanisms  of  ER  stress-induced  apoptosis  in
        10.  McPherson R, Hegele RA: Ezetimibe: rescued by Randomization (Clini-  atherosclerosis. Arterioscler Thromb Vasc Biol 31:2792–2797, 2011.
           cal and Mendelian). Arterioscler Thromb Vasc Biol 35:e13–e15, 2015.  25.  Podrez EA, Byzova TV, Febbraio M, et al: Platelet CD36 links hyper-
        11.  Khetarpal  SA,  Rader  DJ:  Triglyceride-rich  lipoproteins  and  coronary   lipidemia,  oxidant  stress  and  a  prothrombotic  phenotype.  Nat  Med
           artery disease risk: new insights from human genetics. Arterioscler Thromb   13:1086–1095, 2007.
           Vasc Biol 35:e3–e9, 2015.                          26.  Rautou PE, Vion AC, Amabile N, et al: Microparticles, vascular func-
        12.  Moore KJ, Tabas I: Macrophages in the pathogenesis of atherosclerosis.   tion, and atherothrombosis. Circ Res 109:593–606, 2011.
           Cell 145:341–355, 2011.                            27.  Silverstein RL: Type 2 scavenger receptor CD36 in platelet activation:
        13.  Steinberg D, Witztum JL: Oxidized low-density lipoprotein and athero-  the role of hyperlipidemia and oxidative stress. Clin Lipidol 4:767, 2009.
           sclerosis. Arterioscler Thromb Vasc Biol 30:2311, 2010.  28.  Owens AP, 3rd, Passam FH, Antoniak S, et al: Monocyte tissue factor-
        14.  Borissoff  JI,  Spronk  HM,  ten  Cate  H:  The  hemostatic  system  as  a   dependent activation of coagulation in hypercholesterolemic mice and
           modulator of atherosclerosis. N Engl J Med 364:1746, 2011.  monkeys is inhibited by simvastatin. J Clin Invest 122:558–568, 2012.
        15.  Hedrick CC: Lymphocytes in atherosclerosis. Arterioscler Thromb Vasc   29.  Charo IF, Taub R: Anti-inflammatory therapeutics for the treatment of
           Biol 35:253–257, 2015.                                atherosclerosis. Nat Rev Drug Discov 10:365–376, 2011.
        16.  Silverstein  RL,  Febbraio  M:  CD36,  a  scavenger  receptor  involved  in   30.  Nioi  P,  Sigurdsson  A,  Thorleifsson  G,  et al:  Variant  ASGR1  associ-
           immunity,  metabolism,  angiogenesis,  and  behavior.  Sci  Signal  2re3,   ated  with  a  reduced  risk  of  coronary  artery  disease.  N  Engl  J  Med
           2009.                                                 374:2131–22141, 2016.
        17.  Nagy L, Tontonoz P, Alvarez JG, et al: Oxidized LDL regulates macro-  31.  Feinberg MW, Moore KJ: MicroRNA regulation of atherosclerosis. Circ
           phage gene expression through ligand activation of PPARgamma. Cell   Res 118:703–720, 2016.
           93:229–240, 1998.                                  32.  Koeth RA, Wang Z, Levison BS, et al: Intestinal microbiota metabolism
        18.  Mitra S, Deshmukh A, Sachdeva R, et al: Oxidized low-density lipopro-  of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med
           tein and atherosclerosis implications in antioxidant therapy. Am J Med   19:576–585, 2013.
           Sci 342:135–142, 2011.                             33.  Zhu  W,  Gregory  JC,  Org  E,  et al:  Gut  microbial  metabolite TMAO
        19.  Llodrá J, Angeli V, Liu J, et al: Emigration of monocyte-derived cells   enhances platelet hyperreactivity and thrombosis risk. Cell 165:111–124,
           from atherosclerotic lesions characterizes regressive, but not progressive,   2016.
           plaques. Proc Natl Acad Sci USA 101:11779–11784, 2004.  34.  Gregory JC, Buff JA, Org E, et al: Transmission of atherosclerosis suscep-
        20.  Bennett  MR,  Sinha  S,  Owens  GK:  Vascular  smooth  muscle  cells  in   tibility with gut microbial transplantation. J Biol Chem 290:5647–5660,
           atherosclerosis. Circ Res 118:692–702, 2016.          2015.
   2385   2386   2387   2388   2389   2390   2391   2392   2393   2394   2395